Image_01-removebg-preview

TEXAS INSTITUTE OF BIOTECHNOLOGY, education & research

VISION

A world where scientific innovations made possible through biotechnology conquer disease, sustain our environment,  and healthfulness. To offer affordable, safe and effective healthcare solutions to combat mankind’s dreaded illnesses and to thus eradicate or at least control their occurrence in the years to come

MISSION

We seek to address the health care needs of the billion people in the emerging markets by driving innovation and being a frontrunner in research and development of new vaccines and bio-therapeutics. To advance biotechnology innovation by promoting sound public policy and fostering collaboration, both locally and globally.

VACCINE PRODUCING PLATFORM

TEXAS INSTITUTE OF BIOTECHNOLOGY

TIBER was founded in 2012 by North American University in Houston, Texas, USA. TIBER set up different platforms. The same platform  can be  be applied  to different fields

VACCINE PLATFORM: (mRNA vaccine - Recombinant Antigen Vaccine):

  1. Vaccine For Microorganism: TIBER is a biotechnology institute of North American University Houston Texas, USA I that develops technologies and vaccines that stimulate and strengthens  the immune system through active immunization by mRNA vaccine and viral recombinant antigen vaccine  to fight against any kind of  infection such as Covid-19. TIBER specializes in mRNA vaccines and recombinant protein nanoparticle vaccines  for use in the treatment of several infectious diseases, such as the Covid-19.
  2. Vaccine For Cancer Immunotherapy: And also, the same platform can be applied to fight against cancer (Cancer Immunotherapy) through active immunization by mRNA vaccine or recombinant antigen vaccine to against organ  or cancer specific antigens.

Chimeric T-cell Antigen (CAR) PLATFORM

TEXAS INSTITUTE OF BIOTECHNOLOGY

Chimeric T-cell Antigen (CAR) :

  1. CAR For Cancer Treatment: CAR is first-in-class therapeutics in order to treat serious life-threatening cancers such as acute myeloid leukemia (AML) through Chimeric T-cell Antigen (CAR) technique in T-cell or National Killer Cell (NK-cell)
  2. CAR For Autoimmune Disease Treatment: CAR is also, to engage in discovering, developing, manufacturing and marketing therapies for treating autoimmune disorders and neurodegenerative diseases such as Multiple Sclerosis (MS), in the United Sates as well as Internationally.

IN SILICO DRUG SCREENING PLATFORM

TEXAS INSTITUTE OF BIOTECHNOLOGY

(TIBER)-3 IN SILICO DRUG SCREEN

TIBER is a Research Institute specialized  also in screening and developing  anti-disease drugs. For  cancer treatment through anti cancer drugs or  viral infection treatment through anti-viral drugs

  1. Drug Screening For Cancer Treatment: Screening and Discovering anti-vascular (anti-VEGF) and anti-GLUT-1 drugs (inhibitors) to use for cancer treatment through in silico drug screening.
  2.  Anti Viral Screening For Covid-19: Screening and Discovering Anti –RdRp of SARS Co-2 drugs or Anti-RBD of SARS Co-2  drugs to treat patients who were infected by SARS Co-2.

SCREENING AND DEVELOPING HUMAN ANTIBODY PLATFORM

TEXAS INSTITUTE OF BIOTECHNOLOGY

SCREENING AND DEVELOPING HUMAN NEUTRALIZING ANTIBODIES FOR COVID-19 TREATMENT

TIBER is a Research Institute specialized  also in screening and developing   human  neutralizing antibodies  through molecular biology techniques in vitro. Neutralizing antibodies defend healthy cells by interfering with the biological function of an invading virus. These antibodies may be used therapeutically to treat someone currently fighting the disease and can be given to people who have heightened risk of exposure to SARS-CoV-2, such as healthcare workers.

Vaccinesheefa startup company operates in the field of prototype and serial production of COVID and CANCER vaccines, which are developed in universities, research centers, laboratories in the USA.
The Vaccinesheefa startup company aims to collaborate with investors to develop vaccine work.
WE CAN SEND PROPOSAL TO THOSE WHO WANT TO INVEST IN THE VACCINESEEFA STARTUP COMPANY WITH THE NCDA CONTRACT BELOW.

Contact: [email protected]

Biotechnological-Microbial Products Investment Opportunity!

The global antimicrobial coatings market size was valued at USD 7.1 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 12.8% from 2020 to 2027. THE RESEARCHER-EXPERT GROUP HAS MICROBIAL-MICROORGANISM BACTERIA AS A RESULT OF A LONG RESEARCH (ALL EXPERIMENTALLY PROVEN)
Read More…

APPLICATION OF THE PRODUCTS

A. AGRICULTURE

  1. ORGANIC MICROBIAL BIO- FERTILIZERS
  2. ORGANIC MICROBIAL BIO- PESTICIDES
  3. ORGANIC COMPOST PRODUCTION

B. FARM ANIMAL

  1. Probiotic For Cow, Sheep, goat,  Chicken, Bird, Horse, Camel, and Fish
  2. BARN ODOR DESTROYER
  3. AQUARIUM CLEANING
  4. FISH & SHRIMP POND CLEANING
  5. SLAUGHTERHOUSE CLEANING AND

C-GOLD PRODUCTION INDUSTRY

  1. Microbial Degradation Of Cyanide

D- ENVIROMENT

  1. POLLUTED POND CLEANING and ODOR DEGRADATION.
  2. MUNICIPIAL  and INDUSTRIAL SEWER CLEANING &
  3.  ODOR DEGRADATION
  4. MUNICIPIAL  SOLID WASTE & ODOR DEGRADATION
  5. MUNICIPAL AND INDUSTRIAL  PIPE PLUGGED MAINTENANCE

E- OIL SPILL CLEANING

  1. OIL SPILL CLEANING In LAND
  2. OIL SPILL CLEANING In WATER